Meet

I’m Avi Lasarow, a UK-based entrepreneur, philanthropist and campaigner focused on building ventures that deliver meaningful impact at scale, spanning diagnostics, health innovation and infrastructure-led inclusion.

I create companies that take breakthrough science and emerging technologies out of the laboratory and into everyday life, enabling people, institutions and communities to access insights and services that were previously beyond reach.

Over the past two decades, I have led and scaled multiple healthtech businesses through growth and acquisition, including three years as CEO EMEA of global diagnostics and genetic testing company Prenetics at the time of its $1bn plus Nasdaq IPO in 2022.

I have learnt what it takes to translate innovation into commercial adoption at scale. Today, I work with ambitious founders and strategic partners to build disruptive technologies that tackle major societal challenges, create scalable solutions, and drive innovation across industries. I am also an angel investor and mentor to the next generation of entrepreneurs building breakthrough projects with global relevance.

I played a leading role in establishing the UK’s COVID testing infrastructure from scratch, delivering secure environments and national scale programmes for organisations including the Premier League, Virgin Atlantic, Carnival Corporation, The Walt Disney Company, Her Majesty’s Prison and Probation Service, the Ministry of Defence and the UK Home Office.

I was a founding member of the Health Council of the Confederation of British Industry (CBI), and I sat on NHS England Innovation’s Diagnostic Transformation Programme Industry Advisory Group, contributing inputs to senior NHS leaders on emerging needs, technologies and pathways that can improve efficiency and patient outcomes.

I also served as a Special Advisor to the G20 and B20 Digital Transformation Task Force during Africa’s first hosting of the global summit, supporting initiatives that advance digital transformation, inclusion and the future of essential infrastructure.

Today, my primary focus is Finergi, an infrastructure fintech business built on proprietary IP that turns utility meters into credit scores. By converting real time consumption and payment behaviour into trusted affordability and risk signals, Finergi unlocks new pathways for financial inclusion, expands access to essential services, and enables utilities to improve collections, reduce losses and modernise customer engagement across emerging markets.

As a proud South African, I serve as an Honorary Consul to South Africa in the UK, working in a diplomatic capacity to strengthen trade, investment and collaboration between both countries.

Innovator

Innovation, for me, is not simply invention. It is the ability to turn breakthrough ideas into real world products and scale them with trust, compliance and commercial discipline.

Over the past two decades, I have built and led multiple businesses across diagnostics, healthtech and data led innovation, taking technologies from concept to adoption. This included serving as CEO EMEA of Prenetics at the time of its $1bn plus Nasdaq IPO, helping scale a global diagnostics platform.

Today, my primary innovation focus is Finergi, an infrastructure fintech business built on proprietary IP that turns utility meters into credit scores. By converting real time consumption and payment behaviour into affordability signals, Finergi unlocks financial inclusion while helping utilities improve collections, reduce losses and modernise customer engagement across emerging markets.


Find out more

Entrepreneur

As CEO EMEA for Prenetics, Avi Lasarow played a key leadership role in the company’s successful Nasdaq IPO in May 2022, supporting the growth story behind its $1bn plus public listing. In 2021, Avi’s UK based EMEA division contributed more than half of Prenetics’ global $275m revenue.

As a serial entrepreneur, Avi has built and scaled multiple ventures from early stage to acquisition since the early 2000s, earning the Queen’s Award for Enterprise twice along the way. During Prime Minister Theresa May’s visit to South Africa in 2018, Avi’s business DNAfit received a UK Board of Trade Award from the Prime Minister and Secretary of State for International Trade Liam Fox, recognising its contribution to driving cross border investment and innovation. This was the first time a Board of Trade medallion had been awarded outside the United Kingdom.

Avi’s entrepreneurial focus has evolved from pioneering genetics led consumer innovation to building technology platforms with broader infrastructure level impact. Today, his primary focus is Finergi, an infrastructure fintech business built on proprietary IP that turns utility meters into credit scores, unlocking new pathways for financial inclusion and improving utility collections and service resilience across emerging markets. He also served as a Special Advisor to the G20 and B20 Digital Transformation Task Force during Africa’s first hosting of the global summit.


Find out more

Investor

Often ahead of the market, Avi’s experience in founding, investing in, and scaling companies that have achieved multi-million-dollar valuations at exit gives him deep insight into identifying high-potential opportunities and supporting founders through critical growth and scale-up phases, particularly in health-tech.


Find out more

Campaigner

Avi Lasarow has been behind some of UK’s leading health and science campaigns, ranging from the launch of CircleDNA, the world’s most cutting-edge DNA test, to standing up for consumers against rogue COVID testing firms.

He is also a leading supporter of the ‘Everyone Genome’ project, which is addressing disparity in genetic research meaning that medicines developed for white European populations are not as effective for people of African descent.


Find out more

Giving Back

Avi is committed to giving back through mentorship, entrepreneurship and youth development. He supports early stage founders through the City of London’s Worshipful Company of Entrepreneurs and EASI, the Early Stage Innovators Award, and has also supported programmes such as the Duke of Edinburgh’s Award. In 2011, he was appointed Honorary Consul for South Africa to the United Kingdom. In 2025, through his work with Finergi, Avi supported a food donation to an orphanage in Zambia.


Find out more

Public Advocacy and Media

From appearing on BBC’s Today Programme, to writing for The Times, Avi Lasarow is often asked for his views on diagnostic testing and genetics, and on starting, running and selling a business.


Find out more